Zhengye Biotechnology Holding Ltd financial data

Symbol
ZYBT on Nasdaq
Location
No.1 Lianmeng Street, Jilin Economic &, Technical Development Zone, Jilin, China
Latest financial report
20-F - Q4 2024 - Jul 3, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 45.7M shares
Common Stock, Shares, Outstanding 45.7M shares 0%
Common Stock, Value, Issued 1K USD

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.55M USD
Marketable Securities, Current 183K USD
Accounts Receivable, after Allowance for Credit Loss, Current 8.16M USD
Inventory, Net 7.98M USD
Assets, Current 24.3M USD
Deferred Income Tax Assets, Net 1.51M USD
Property, Plant and Equipment, Net 35M USD
Assets 67.6M USD
Accounts Payable, Current 5.89M USD
Contract with Customer, Liability, Current 477K USD
Liabilities, Current 18.6M USD
Liabilities 19.3M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax 3K CNY
Retained Earnings (Accumulated Deficit) 6.6M USD
Stockholders' Equity Attributable to Parent 38.9M USD
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 48.3M USD
Liabilities and Equity 67.6M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 2B shares 0%
Common Stock, Shares, Issued 45.7M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.55M USD -31.6%
Deferred Tax Assets, Valuation Allowance 18K USD
Deferred Tax Assets, Gross 1.52M USD
Property, Plant and Equipment, Gross 48.9M USD
Deferred Tax Assets, Operating Loss Carryforwards 100K USD
Deferred Tax Assets, Net of Valuation Allowance 1.51M USD